Digital PCR has proven to be a valuable technique to detect EGFR and Kirsten rat sarcoma virus (KRAS) gene mutations in CTCs from non-small-cell lung cancer patients, demonstrating its potential as a liquid biopsy for monitoring treatment response [106,107]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.